Pelvic extrusion in patients with cervical cancer: clinical experience


DOI: https://dx.doi.org/10.18565/pharmateca.2023.6-7.54-58

G.A. Khakimov, G.G. Khakimova, Kh.U. Musurmonov, Sh.G. Khakimova, G.P. Orifzhonova

1) Tashkent city Branch of the Republican Specialized Scientific and Practical Medical Center of Oncology and Radiology, Tashkent, Uzbekistan; 2) Tashkent Pediatric Medical Institute. Tashkent, Uzbekistan; 3) Nano Medical Clinic, Tashkent, Uzbekistan
Despite the achievements in performing small pelvic exenteration (SPE) in the world oncological practice, it still remains a debatable subject for practicing oncological surgeons. The main reasons for its unpopularity include technical complexity, high incidence of intra- and postoperative complications (60%), high postoperative mortality (30%), and problems in postoperative rehabilitation of patients [1–3]. This article provides an analysis of 20 SPEs (10 anterior; 10 total) in recurrent locally advanced forms of cervical cancer.

About the Autors


Corresponding author: Gulnoz G. Khakimova, Cand. Sci. (Med.), Associate Professor at the Department of Pediatric Oncology, Tashkent Pediatric Medical Institute; Oncologist-Chemotherapist at the Nano Medical Clinic Tashkent, Uzbekistan; hgg_doc@mail.ru


Similar Articles


Бионика Медиа